1IDSA: Antimicrobial Agents in Neutropenic Patients With CancerPrompt cultures, broad empiric antibacterial therapy, risk assessment, and response monitoring
2IDSA 2024 Guidance on Antimicrobial-Resistant Gram-Negative InfectionsCarbapenem preference for ESBL-producing infections outside the urinary tract and treatment refinement